Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can the right electric pulse calm chronic worry?

NCT ID NCT07798986

Symptom relief Sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 02, 2026 · Last updated Sep 03, 2026 · Updated 1 time

Summary

This trial tests whether different electroacupuncture frequencies can ease symptoms of generalized anxiety disorder, a condition marked by persistent, excessive worry. Researchers will compare three stimulation patterns (2 Hz, 100 Hz, and a mixed 2/100 Hz wave) against a sham version in 120 adults aged 18 to 60. Each participant receives 12 sessions over four weeks, and the team measures anxiety using standard rating scales. The goal is to find out which setting, if any, provides the most relief.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Electroacupuncture at different frequencies (2 Hz, 100 Hz, and 2/100 Hz dense-disperse wave) compared with sham electroacupuncture
What this could lead to
If it works, this could identify the most effective electroacupuncture settings for easing anxiety, offering a drug-free option for people with generalized anxiety disorder.
What could go wrong
The trial is relatively small and early, and it compares different versions of the same treatment, so any difference between them may be modest. Results depend on how well participants respond, and electroacupuncture may not work for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 120 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Dec 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 60 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Only those who meet the following four criteria simultaneously can be included in this study: 1. Meet the diagnostic criteria for GAD; 2. Between 18 and 60 years old; 3. Conscious and able to communicate normally; 4. Have good compliance, be willing to cooperate with the study, and sign the informed consent form. Exclusion Criteria: Exclude patients meeting any of the following criteria: 1. Organic mental disorder, schizophrenia, bipolar disorder, mania/other psychoses, alcohol/drug addiction, current drug use disorder/lifetime drug abuse, post-stroke/postpartum anxiety; 2. History of suicidal behavior or severe suicidal tendency; 3. Pregnancy or breastfeeding; 4. Mental retardation, unable to cooperate; 5. Electroacupuncture contraindications: bleeding tendency, coagulation dysfunction, internal metal implants; 6. Participation in other clinical trials within 1 month.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Generalized anxiety disorder (GAD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

generalized anxiety disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Generalized anxiety disorder (GAD)

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • 2nd Affiliated Hospital, School of Medicine, Zhejiang University, China

    Hangzhou, Zhejiang, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.